DRAK2 Blocking Peptide Summary
15 amino acids near the carboxy terminus of human DRAK2. Accession #: AB011421.
Source: Synthetic
Blocking Peptide
STK17B
N/A
Applications/Dilutions
Can be used to block the binding of NBP1-76885
Packaging, Storage & Formulations
Store at -20C. Avoid freeze-thaw cycles.
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
0.02% Sodium Azide
0.2 mg/ml
N/A
Alternate Names for DRAK2 Blocking Peptide
- DAP kinase-related apoptosis-inducing protein kinase 2
- DRAK2
- DRAK2death-associated protein kinase-related 2
- EC 2.7.11
- EC 2.7.11.1
- serine/threonine kinase 17b (apoptosis-inducing)
- serine/threonine kinase 17b
- serine/threonine-protein kinase 17B
- STK17B
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets :　Amyloid-(beta) inhibitors